ExamWorks Group (NYSE: EXAM) reported earnings on Feb. 27. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 31 (Q4), ExamWorks Group beat expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. GAAP loss per share shrank.

Gross margins shrank, operating margins expanded, net margins grew.

Revenue details
 ExamWorks Group reported revenue of $139.6 million. The four analysts polled by S&P Capital IQ wanted to see a top line of $135.6 million on the same basis. GAAP reported sales were 21% higher than the prior-year quarter's $115.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.08. The four earnings estimates compiled by S&P Capital IQ forecast -$0.16 per share. GAAP EPS were -$0.08 for Q4 against -$0.15 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 33.7%, 40 basis points worse than the prior-year quarter. Operating margin was 1.4%, 90 basis points better than the prior-year quarter. Net margin was -1.9%, 250 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $148.2 million. On the bottom line, the average EPS estimate is -$0.06.

Next year's average estimate for revenue is $606.1 million. The average EPS estimate is -$0.33.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 16 members out of 27 rating the stock outperform, and 11 members rating it underperform. Among 10 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give ExamWorks Group a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ExamWorks Group is outperform, with an average price target of $16.17.

Is ExamWorks Group the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.